Groningen-based Ivy Medicals, a medtech startup specialised in infusion therapy through advanced automation, has officially filed for bankruptcy.
The announcement was made by founder and CEO Melcher Frankema through a LinkedIn post.
Contentlockr
“In recent years, we have worked with a fantastic team and committed partners on an innovative infusion system. This has resulted in a fully working product, ready for the final test phase towards CE certification and market introduction. Fewer alarms, fewer actions, more time for nurses and patients. An innovation that, precisely because of the increasing pressure on healthcare, is desperately needed,” says Frankema.
Reason behind bankruptcy
Since mid-2024, the Dutch company had been actively seeking investment to transition into a cash-flow-positive phase and scale its operations.
Despite strong support from team members, partners, and institutions, the funding round fell short, leading to the company’s closure.
“That’s just a shame. For our team, for our partners, and especially for the nurses and patients who counted on us,” he says. “We have built something valuable. We have learned a lot, have grown, and together with the Radboudumc, among others, have gained important knowledge and experience that remains. Knowledge that will ultimately benefit healthcare.”
He also expressed his openness to new professional opportunities in healthcare innovation and entrepreneurship.
Ivy Medical: Enhancing infusion therapy
Founded in 2017, Ivy Medical is enhancing infusion therapy through automation to improve healthcare efficiency.
The company’s primary product, the Ivy Duo+, is a smart infusion pump that helps nurses save up to 30 minutes per patient each day by reducing routine tasks.
This change allows them to focus more on patient care. The company’s technology also helps staff manage their workload better and allows hospitals to use resources more effectively, improving the quality of infusion therapy.
